
Friday May 15, 2026
Monoclonal antibodies and Chinese mice
Brendan and Joanna are joined by immunologist Dr. Paul Ibbett to unpack the biologic therapies Brendan is using for his optic neuritis.
What's covered
- Biologics vs. monoclonal antibodies, and how they're manufactured in Chinese hamster ovary cell lines
- Why ~90% of drugs fail, and how AI/ML is improving antibody design
- The blood-brain barrier and why it makes neurology so hard to treat
- The immune system as a "spider's web" — B cells, T cells, and TNF-alpha
- Brendan's journey: Rituximab didn't work, now on infliximab (a TNF-alpha blocker), with steroids tapering
- How inflammation damages the optic nerve, and a possible Behçet's disease diagnosis
No comments yet. Be the first to say something!